nicotinamide mononucleotide has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badalzadeh, R; Chodari, L; Ghaffari, S; Høilund-Carlsen, PF; Mokhtari, B; Yasami, M | 1 |
| Byun, J; Ikeda, Y; Oka, S; Sadoshima, J; Yamamoto, T; Zhai, P | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Heart Disease, Ischemic
| Article | Year |
|---|---|
Melatonin/nicotinamide mononucleotide/ubiquinol: a cocktail providing superior cardioprotection against ischemia/reperfusion injury in a common co-morbidities modelled rat.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Infarction; Ischemia; Male; Melatonin; Morbidity; Myocardial Ischemia; Myocardial Reperfusion Injury; Nicotinamide Mononucleotide; Rats; Rats, Wistar | 2023 |
Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Topics: Animals; Caloric Restriction; Cardiotonic Agents; Heart; Ischemic Preconditioning; Male; Mice; Myocardial Infarction; Myocardial Ischemia; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Reperfusion Injury; Sirtuin 1; Up-Regulation | 2014 |